AspirinAsthmaAnti-Inflammatory Agents, Non-SteroidalPlatelet Aggregation InhibitorsSensitivity and SpecificityCyclooxygenase InhibitorsThromboxane B2TiclopidineIbuprofenPlatelet AggregationAnti-Asthmatic AgentsSalicylatesCyclooxygenase 2 InhibitorsDrug Therapy, CombinationPlatelet Function TestsNaproxenAsthma, Aspirin-InducedDiclofenacGastrointestinal HemorrhageRisk FactorsCyclooxygenase 1Dose-Response Relationship, DrugBlood PlateletsProstaglandin-Endoperoxide SynthasesDouble-Blind MethodSodium SalicylateStomach UlcerAcetaminophenGastrointestinal DiseasesFibrinolytic AgentsTime FactorsProspective StudiesCyclooxygenase 2Asthma, Exercise-InducedHemorrhageTreatment OutcomeAnticoagulantsWarfarinTablets, Enteric-CoatedPeptic Ulcer HemorrhagePeptic UlcerDrug ResistanceAdministration, InhalationBleeding TimePlatelet ActivationGastric MucosaThromboxanesPeak Expiratory Flow RateDrug HypersensitivityThromboxane A2Forced Expiratory VolumeFlurbiprofenThrombosisAdrenal Cortex HormonesDipyridamoleCase-Control StudiesAsthma, OccupationalCohort StudiesBronchial HyperreactivityFollow-Up StudiesBronchodilator AgentsPiroxicamRespiratory SoundsProstaglandinsLipoxinsMyocardial InfarctionDrug InteractionsAllergensDinoprostoneEtodolacIndomethacinPyrazolesRhinitisSulfonamidesDrug Administration ScheduleRisk AssessmentAnti-Inflammatory AgentsHypersensitivityIncidenceRandomized Controlled Trials as TopicProton Pump InhibitorsStrokeSulfinpyrazoneQuestionnairesSeverity of Illness IndexReye SyndromeAnti-Ulcer AgentsKetoprofenPrimary PreventionSulfonesOdds RatioPrevalenceHypersensitivity, Immediate